Elixinol Wellness Archives | Cannabiz

Cannabis executive salaries: who earned what in FY26

by Adam Sheldon October 15, 2026October 19, 2026

Another year of financial pressure, boardroom upheaval and regulatory scrutiny tested executives running Australia’s ASX-listed cannabis […]

Elixinol hemp sales climb 12% as gross profit jumps 41%

by Adam Sheldon October 13, 2026October 13, 2026

News in brief: Canopy expands Australian portfolio; Neurotech CEO departs; Elixinol completes US sale

by Adam Sheldon September 8, 2026September 9, 2026

Elixinol cuts H1 loss and announces deal to sell US hemp business

by Adam Sheldon September 2, 2026September 3, 2026

Financial news in brief: Elixinol record quarter; Avecho identifies new trial sites

by Steve Jones July 29, 2026July 30, 2026

News in brief: Cannaponics raise tops $2.5m; Avecho receives $1.98m R&D incentive; Elixinol backs capital raising plans

by Adam Sheldon May 27, 2026June 8, 2026

E-commerce surge lifts Elixinol margins in FY25 but losses deepen

by Adam Sheldon March 3, 2026March 5, 2026

Elixinol records first underlying operating cash flow positive quarter

by Adam Sheldon February 2, 2026February 3, 2026

Elixinol names new chair in pursuit of ‘sustainable and profitable business’

by Steve Jones December 2, 2025February 21, 2026

News in brief: Elixinol names new CEO; Aurora flags MedReleaf growth; InhaleRx R&D tax rebate; ODC to ‘share insights’; Tilray appoints new Australian director

by Steve Jones June 20, 2025June 26, 2025